Circulating antioxidant defences are decreased in healthy people after a high-fat meal

British Journal of Nutrition

Volumn 100, Issue 2, 2008, Pages 312-316

  Cardona, Fernando ^a,b   Túnez, Isaac ^c   Tasset, Inmaculada ^c   Garrido Sánchez, Lourdes ^a,b   Collantes, Eduardo ^d   Tinahones, Francisco José ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Universidad de Cordoba   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

High fat meal; Oxidative stress; Postprandial hyperlipidaemia; Uric acid

Indexed keywords

ANTIOXIDANT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN DERIVATIVE; URIC ACID;

ADULT; ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID DIET; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN MODIFICATION; URIC ACID BLOOD LEVEL;

ADULT; ANTIOXIDANTS; BLOOD PROTEINS; CHOLESTEROL, HDL; DIETARY FATS; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; POSTPRANDIAL PERIOD; TRIGLYCERIDES; URIC ACID;

EID: 52949103718     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507894347     Document Type: Article

References (38)

1. Karpe F, Steiner G, Uffelman K, Olivecrona T & Hamsten A (1994) Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106, 83-97.
2. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn SK, Gotto AM & Patsch W (1992) Relation of triglyceride metabolism and coronary artery disease. Arterioscler Thromb 12, 1336-1345.
3. Cardona F & Tinaliones FJ (2006) Relación de la hipertrigliceridemia postprandial con la resistencia a la insulina en pacientes con síndrome metabólico. Endocrinol Nutr 53, 345-352.
4. Bae JH, Bassenge E, Kim KB, Kim YN, Kim KS, Lee HJ, Park KY & Schwemmer M (2001) Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 155, 517-523.
5. De Koning EJ & Rabelink TJ (2002) Endothelial function in the postprandial state. Atheroscler Suppl 3, 11-16.
6. Tinahones FJ, Collantes E, C-Soriguer FJ, Gonzalez-Ruiz A, Pineda M, Anon J & Sánchez Guijo P (1995) Increased VLDL levels and diminished renal excretion of uric acid in hyperurieaemic-hypertriglyceridaemic patients. Br J Rheumatol 34, 920-924.
7. Tinahones JF, Perez-Lindon G, C-Soriguer FJ, Pareja A, Sanchez-Guijo P & Collantes E (1997) Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab 82, 1188-1191.
8. Cardona F, Tinahones FJ, Collantes E, Escudero A, Garcia-Fuentes E & Sorigner FJ (2005) Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout. Ann Rheum Dis 64, 85-88.
9. Cardona F, Tinahones FJ, Collantes E, Escudero A, Garcia-Fuentes E & Soriguer FJ (2003) The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates. Rheumatology (Oxford) 42, 469-472.
10. Berry CE & Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications. J Physiol 16, 589-606.
11. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF & Barnett AH (1997) Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur. J Clin Invest 27, 484-490.
12. Benzie IF, Chung W & Tomlinson B (1999) Simultaneous measurement of allantoin and urate in plasma: Analytical evaluation and potential clinical application in oxidant:aNtioxidant balance studies. Clin Chem 45, 901-904.
13. Lohmann TG, Roche AF & Martorell R (editors) (1988) Anthropometric Standardization Reference Manual, Champaign, IL: Human Kinetics Books.
14. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S & Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186, 464-478.
15. Ricart-Jané D, Llobera M & López-Tejero MD (2002) Anticoagulants and other preanalytical factors interfere in plasma nitrate/nitrite quantification by the Griess method. Nitric Oxide 6, 178-185.
16. Flohé L & Gunzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105, 114-121.
17. Aebi H (1984) Catalase in vitro. Methods Enzymol 105, 121-126.
18. Marklund SL (1990) Analysis of extracellular superoxide dismutase in tissue homogenates and extracellular fluids. Methods Enzymol 186, 260-265.
19. Manuel-y-Keenoy B, Van Compenhout A, Aerts P, Vertommen J, Abrams P, Van Gaal LF, Van Gils C & De Leeuw IH (2005) Time course of oxidative stress status in the post-prandial and postabsorptive states in type 1 diabetes mellitus: Relationship to glucose and lipid changes. J Am Coll Nutr 24, 474-485.
20. Ursini F & Sevanian A (2002) Postprandial oxidative stress. Biol Chem 383, 599-605.
21. Bowen PE & Borthakur G (2004) Postprandial lipid oxidation and cardiovascular disease risk. Curr Atheroscler Rep 6, 477-484.
22. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M & Shimomura I (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761.
23. Porter M, Pearson DJ, Suarez-Mendez VJ & Blann AD (1992) Plasma, platelet and erythrocyte glutathione peroxidases as risk factors in ischemic heart disease in man. Clin Sci 83, 343-345.
24. Lapenna D, de Gioia S, Ciofani G, Mezzetti A, Ucchino S, Calafiore AM, Napolitano AM, Di Ifio C & Cuecurullo F (1998) Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 97, 1930-1934.
25. Roxborough HE, Mercer C, McMaster D, Maxwell AP & Young S (1999) Plasma glutathione peroxidase activity is reduced in hemodialysis patients. Nephron 81, 278-283.
26. Glantzounis GK, Tsimoyiannis EC, Kappas AM & Galaris DA (2005) Uric acid and oxidative stress. Carr Pharm Des 11, 4145-4151.
27. Ames BN, Cathcart R, Schwiers E & Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant-and radical caused aging and cancer: A hypothesis. Proc Natl Acad Sci U S A 78, 6858-6862.
28. Davies KJ, Sevanian A, Muakkassah-Kelly SF & Hochstein P (1996) Uric acid-iron ion complexes. A new aspect of the anti-oxidant functions of uric acid. Biochem J 235, 747-754.
29. Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, Mazzali M & Johnson RJ (2002) Uric acid, hominoid evolution, and the pathogenesis of salt sensitivity. Hypertension 40, 355-360.
30. Waring WS, Webb DJ & Maxwell SR (2001) Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38, 365-371.
31. Mikami T, Yoshino Y & Ito A (2000) Does a relationship exist between the urate pool in the body and lipid peroxidation during exercise? Free Radic Res 32, 31-39.
32. Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ & Maxwell SR (2003) Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci -(Lond) 105, 425-430.
33. Kaur H & Halliwell B (1990) Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. Chem Biol Interact 73, 235-247.
34. Franse LV, Pahor M, Di Bari M, Shorr RI, Wan JY, Somes GW & Applegate WB (2000) Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 18, 1149-1154.
35. Nieto FJ, Iribarren C, Gross MD, Comstock GW & Cutler RG (2000) Uric acid and serum antioxidant capacity: A reaction to atherosclerosis? Atherosclerosis 148, 131-139.
36. Yu ZF, Bruce-Keller AJ, Goodman Y & Mattson MP (1998) Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 93 613-625.
37. Hoey BM & Butler J (1984) The repair of oxidized amino acids by antioxidants. Biochim Biophys Acta 791, 212-218.
38. Halliwell B & Gutteridge JMC (1999) Antioxidant protection by low molecular-mass agents: Compounds synthesized in vivo. In Free Radicals in Biology and Medicine, pp. 195-197 [B Halliwell and JMC Gutteridge, editors]. Oxford: Oxford University Press.